Back to search results

Observational Study for Health Conditions and Biomarker Identification

This is an observational study aiming to understand health conditions like Lupus, Celiac disease, and kidney disease better. Researchers will collect health data, lifestyle information, and biological samples from participants. This information will then be shared with other researchers to help develop new tests, treatments, and cures. The study is looking for 100,000 participants, aged 18 to 90, who have reviewed and signed a consent form. The main goal is to identify biomarkers (biological signs) over a 10-year period that could lead to new discoveries. The study is currently recruiting participants.

Study design
This is an observational study with a planned enrollment of 100,000 participants. It is non-interventional, meaning no specific treatments are given.
What's involved
Participants will provide health data, lifestyle information, biological samples, and feedback. This may also include interviews, surveys, and other minimal risk research activities.
Compensation
Not stated in the trial record.
Follow-up
Participants will be observed for biomarker identification over 10 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07128966

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

Recruiting
Not specifiedAges 18–90Observational
Joined Bio
~100,000 participants
Updated 2026-05-05 on ClinicalTrials.gov
What's tested:Observation

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Observation for biomarker identification
Measured over 10 years

Conditions

Healthy
Lupus
Celiac
Kidney Disease
Chronic
Dermatologic

Explore related trials

Celiac DiseaseChronic Kidney DiseaseHealthyRare DisorderSkin DisorderSystemic Lupus Erythematosus

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Chris Ianelli, MD · PRINCIPAL_INVESTIGATOR · Joined Bio

Who to contact

Emily L Hubbard, BS Biology
[email protected]
12567970003
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Male or female, that are adults \[have reached the Age of Majority = aged 18 to 90 in most US states; aged 19-90 in Alabama or Nebraska; aged 21-90 in Mississippi or Puerto Rico\].
Have reviewed and signed a consent or e-consent form for this study. If a person with diminished decision-making capacity, their Legally Authorized Representative has reviewed and signed the consent for on their behalf.
Be willing to comply with all study procedures and be available for the duration of the study.
Meets requirements of a current request for research participation (e.g. has previous diagnosis of a medical condition of interest or laboratory results within a specific range).
Pregnant women may be enrolled in this study in accordance with 45 CFR Part 46 Subpart B.
Prisoners or children
Unable to provide the requested biospecimen(s), data or feedback without placing the individual at risk.

What this trial measures

  • Observation for biomarker identification10 years

    There is no defined study outcome. Rather this is an observational study of multiple participant populations that hopes to identify new biomarkers, treatments and/or diagnostic applications.